Skip to main content

Table 3 Predictive KHORANA model for chemotherapy-associated VTE in ambulatory cancer patients [38]

From: Venous thromboembolism in cancer patients: an underestimated major health problem

Risk factors Number
Cancer-related risk factors  
 Site of cancer and tumor histotype 2
 Very high risk (stomach adenocarcinoma, pancreas 1
adenocarcinoma)  
 High risk (lung, lymphoma, gynecological, bladder,  
testicular) 1
Hematological risk factors 1
 Prechemotherapy platelet count ±350,000/l 1
 Hemoglobin <10 g/dl or use of ESA growth factors  
 Prechemotherapy leukocyte count >11 000/l 1
Patient-related risk factor  
 Body mass index ±35 kg/m2